D-Index & Metrics Best Publications

Hanneke C. Kluin-Nelemans

University Medical Center Groningen
Netherlands

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 73 Citations 18,954 311 World Ranking 15761 National Ranking 555

Overview

What is she best known for?

The fields of study Hanneke C. Kluin-Nelemans is best known for:

Gene
Bone marrow
Chemotherapy

Her work focuses on many connections between Barcode and other disciplines, such as Operating system, that overlap with her field of interest in Standardization. Her multidisciplinary approach integrates Standardization and Operating system in her work. Her research on Immunology frequently connects to adjacent areas such as Myeloid leukaemia. Her study brings together the fields of Immunology and Myeloid leukaemia. As part of her studies on Internal medicine, she often connects relevant subjects like Complete remission. She regularly ties together related areas like Cutaneous Mastocytosis in her Bone marrow studies. Hanneke C. Kluin-Nelemans frequently studies issues relating to Bone marrow and Cutaneous Mastocytosis. In her research, she performs multidisciplinary study on Haematopoiesis and Leukemia. She brings together Leukemia and Myeloid leukemia to produce work in her papers.

Her most cited work include:

Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria (646 citations)
Treatment of Older Patients with Mantle-Cell Lymphoma (423 citations)
Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization (186 citations)

What are the main themes of her work throughout her whole career to date

Hanneke C. Kluin-Nelemans performs integrative Internal medicine and Gastroenterology research in her work. In her papers, she integrates diverse fields, such as Gastroenterology and Internal medicine. Hanneke C. Kluin-Nelemans conducts interdisciplinary study in the fields of Immunology and Antibody through her research. Hanneke C. Kluin-Nelemans combines Antibody and Immunology in her research. She performs multidisciplinary study on Lymphoma and Mantle cell lymphoma in her works. Her Surgery study typically links adjacent topics like Transplantation. Her research on Transplantation frequently links to adjacent areas such as Surgery. She performs integrative Oncology and Chemotherapy research in her work. In her research, Hanneke C. Kluin-Nelemans performs multidisciplinary study on Chemotherapy and Oncology.

Hanneke C. Kluin-Nelemans most often published in these fields:

Internal medicine (60.00%)
Immunology (52.50%)
Gastroenterology (32.50%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Eva Hoster;Martin Dreyling;Wolfram Klapper;Christian Gisselbrecht.
Blood (2006)

953 Citations

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.

P. Valent;C. Akin;L. Escribano;M. Födinger.
European Journal of Clinical Investigation (2007)

838 Citations

Double-hit B-cell lymphomas

Sietse M. Aukema;Reiner Siebert;Ed Schuuring;Gustaaf W. van Imhoff.
Blood (2011)

783 Citations

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network

Martin Dreyling;Georg Lenz;Eva Hoster;Achiel Van Hoof.
Blood (2004)

721 Citations

Morbidity and mortality in adults with idiopathic thrombocytopenic purpura

Johanna E. A. Portielje;Rudi G. J. Westendorp;Hanneke C. Kluin-Nelemans;Anneke Brand.
Blood (2001)

657 Citations

Treatment of Older Patients with Mantle-Cell Lymphoma

H. C. Kluin-Nelemans;Eva Hoster;Olivier Hermine;J. Walewski.
The New England Journal of Medicine (2012)

569 Citations

Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders

Francesca Bonifazi;Antonio de Vivo;Gianantonio Rosti;François Guilhot.
Blood (2001)

427 Citations

High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962

Philip M.P. Poortmans;Hanneke C. Kluin-Nelemans;Hanny Haaxma-Reiche;Mars Van’t Veer.
Journal of Clinical Oncology (2003)

393 Citations

Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes.

J.H. Frederik Falkenburg;Amon R. Wafelman;Peter Joosten;Willem M. Smit.
Blood (1999)

364 Citations

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

Jason Gotlib;Hanneke C. Kluin-Nelemans;Tracy I. George;Cem Akin.
The New England Journal of Medicine (2016)

363 Citations

If you think any of the details on this page are incorrect, let us know.